Caris Life Sciences (CAI) Non-Current Assets (2024 - 2026)

Caris Life Sciences' Non-Current Assets history runs 3 years deep, the most recent figure standing at $148.2 million for Q1 2026.

• In Q1 2026, Non-Current Assets changed N/A year-over-year to $148.2 million; the TTM figure through Mar 2026 stood at $528.1 million (changed N/A YoY), while the FY2025 annual figure was $127.9 million, changed 0.11% from the prior year.
• Non-Current Assets was $148.2 million for Q1 2026 at Caris Life Sciences, up from $127.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $148.2 million in Q1 2026 to a low of $121.7 million in Q2 2025.
• Historically, Non-Current Assets has averaged $131.2 million across 3 years, with a median of $128.0 million in 2024.
• Biggest YoY gain for Non-Current Assets was 0.11% in 2025; the steepest drop was 0.11% in 2025.
• A 3-year view of Non-Current Assets shows it stood at $128.0 million in 2024, then retreated by 0.11% to $127.9 million in 2025, then grew by 15.91% to $148.2 million in 2026.
• The last three Non-Current Assets figures came in at $148.2 million (Q1 2026), $127.9 million (Q4 2025), and $130.3 million (Q3 2025), per Business Quant data.